270 related articles for article (PubMed ID: 38473357)
21. Recent advances in understanding pancreatic cancer.
Stott MC; Oldfield L; Hale J; Costello E; Halloran CM
Fac Rev; 2022; 11():9. PubMed ID: 35509672
[TBL] [Abstract][Full Text] [Related]
22. Microbiome and pancreatic ductal adenocarcinoma.
Tijeras-Raballand A; Hilmi M; Astorgues-Xerri L; Nicolle R; Bièche I; Neuzillet C
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101589. PubMed ID: 33607375
[TBL] [Abstract][Full Text] [Related]
23. Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options.
Kabacaoglu D; Ciecielski KJ; Ruess DA; Algül H
Front Immunol; 2018; 9():1878. PubMed ID: 30158932
[TBL] [Abstract][Full Text] [Related]
24. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities.
Bogut A; Stojanovic B; Jovanovic M; Dimitrijevic Stojanovic M; Gajovic N; Stojanovic BS; Balovic G; Jovanovic M; Lazovic A; Mirovic M; Jurisevic M; Jovanovic I; Mladenovic V
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958483
[TBL] [Abstract][Full Text] [Related]
25. Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment.
Schweickert PG; Yang Y; White EE; Cresswell GM; Elzey BD; Ratliff TL; Arumugam P; Antoniak S; Mackman N; Flick MJ; Konieczny SF
J Thromb Haemost; 2021 Jan; 19(1):161-172. PubMed ID: 33064371
[TBL] [Abstract][Full Text] [Related]
26. Metagenomic analysis of gut microbiome reveals a dynamic change in Alistipes onderdonkii in the preclinical model of pancreatic cancer, suppressing its proliferation.
Lee K; Oh HJ; Kang MS; Kim S; Ahn S; Kim MJ; Kim SW; Chang S
Appl Microbiol Biotechnol; 2021 Nov; 105(21-22):8343-8358. PubMed ID: 34648062
[TBL] [Abstract][Full Text] [Related]
27. High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma.
Pan Y; Gao J; Lin J; Ma Y; Hou Z; Lin Y; Wen S; Pan M; Lu F; Huang H
Front Endocrinol (Lausanne); 2023; 14():1181538. PubMed ID: 37347110
[TBL] [Abstract][Full Text] [Related]
28. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.
Riquelme E; Zhang Y; Zhang L; Montiel M; Zoltan M; Dong W; Quesada P; Sahin I; Chandra V; San Lucas A; Scheet P; Xu H; Hanash SM; Feng L; Burks JK; Do KA; Peterson CB; Nejman D; Tzeng CD; Kim MP; Sears CL; Ajami N; Petrosino J; Wood LD; Maitra A; Straussman R; Katz M; White JR; Jenq R; Wargo J; McAllister F
Cell; 2019 Aug; 178(4):795-806.e12. PubMed ID: 31398337
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?
Tjomsland V; Sandström P; Spångeus A; Messmer D; Emilsson J; Falkmer U; Falkmer S; Magnusson KE; Borch K; Larsson M
BMC Cancer; 2010 Mar; 10():87. PubMed ID: 20214814
[TBL] [Abstract][Full Text] [Related]
30. The Prospect of Harnessing the Microbiome to Improve Immunotherapeutic Response in Pancreatic Cancer.
Rogers S; Charles A; Thomas RM
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136254
[TBL] [Abstract][Full Text] [Related]
31. Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer.
Kaune T; Griesmann H; Theuerkorn K; Hämmerle M; Laumen H; Krug S; Plumeier I; Kahl S; Junca H; Gustavo Dos Anjos Borges L; Michl P; Pieper DH; Rosendahl J
iScience; 2023 Jun; 26(6):106841. PubMed ID: 37255660
[TBL] [Abstract][Full Text] [Related]
32. Immune evasion on the nanoscale: Small extracellular vesicles in pancreatic ductal adenocarcinoma immunity.
Fyfe J; Dye D; Razak NBA; Metharom P; Falasca M
Semin Cancer Biol; 2023 Nov; 96():36-47. PubMed ID: 37748738
[TBL] [Abstract][Full Text] [Related]
33. CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
Choueiry F; Torok M; Shakya R; Agrawal K; Deems A; Benner B; Hinton A; Shaffer J; Blaser BW; Noonan AM; Williams TM; Dillhoff M; Conwell DL; Hart PA; Cruz-Monserrate Z; Bai XF; Carson WE; Mace TA
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581043
[TBL] [Abstract][Full Text] [Related]
34. Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma.
Rohila D; Park IH; Pham TV; Weitz J; Hurtado de Mendoza T; Madheswaran S; Ishfaq M; Beaman C; Tapia E; Sun S; Patel J; Tamayo P; Lowy AM; Joshi S
Cancer Res; 2023 Aug; 83(16):2675-2689. PubMed ID: 37306759
[TBL] [Abstract][Full Text] [Related]
35. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
Lee AYL; Dubois CL; Sarai K; Zarei S; Schaeffer DF; Sander M; Kopp JL
Gut; 2019 Mar; 68(3):487-498. PubMed ID: 29363536
[TBL] [Abstract][Full Text] [Related]
36. Roles of microbiota in pancreatic cancer development and treatment.
Cruz MS; Tintelnot J; Gagliani N
Gut Microbes; 2024; 16(1):2320280. PubMed ID: 38411395
[TBL] [Abstract][Full Text] [Related]
37. Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy.
Bhoopathi P; Mannangatti P; Das SK; Fisher PB; Emdad L
Adv Cancer Res; 2023; 159():285-341. PubMed ID: 37268399
[TBL] [Abstract][Full Text] [Related]
38. Human microbiota colonization and pancreatic ductal carcinoma.
Fang Y; Yang G; Yang J; Ren J; You L; Zhao Y
Crit Rev Microbiol; 2023 Aug; 49(4):455-468. PubMed ID: 35924947
[TBL] [Abstract][Full Text] [Related]
39. Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells.
Yu Q; Newsome RC; Beveridge M; Hernandez MC; Gharaibeh RZ; Jobin C; Thomas RM
Gut Microbes; 2022; 14(1):2112881. PubMed ID: 35980869
[TBL] [Abstract][Full Text] [Related]
40. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
